As the deadline for a ₹974 crore rare disease fund ends, CureSMA urged the government to act swiftly. At a virtual press meet ...
It is the leading genetic cause of death among children worldwide as well. While globally approved treatments—Spinraza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback